Tagged: First Systemic Gene Therapy

Genprex’s REQORSA™ Immunogene Therapy: The First Systemic Gene Therapy Used for Cancer

Genprex, a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, is a leader in gene therapy with a systemic gene therapy in development for non-small cell lung cancer (NSCLC).

Read More